OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antiepileptogenesis in humans
Eugen Trinka, Francesco Brigo
Current Opinion in Neurology (2014) Vol. 27, Iss. 2, pp. 227-235
Closed Access | Times Cited: 63

Showing 26-50 of 63 citing articles:

Challenges in the Clinical Development of New Antiepileptic Drugs
Stefan Schwabe
Therapeutic Drug Monitoring (2002) Vol. 24, Iss. 1, pp. 81-84
Closed Access | Times Cited: 50

A systems level analysis of epileptogenesis-associated proteome alterations
Michael Keck, Anna Fournier, F. Gualtieri, et al.
Neurobiology of Disease (2017) Vol. 105, pp. 164-178
Open Access | Times Cited: 26

Dysregulated Glucose Metabolism as a Therapeutic Target to Reduce Post-traumatic Epilepsy
Jenny Koenig, Chris G. Dulla
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 26

Post‐stroke seizure risk prediction models: a systematic review and meta‐analysis
Seong Hoon Lee, Kah Long Aw, Snehashish Banik, et al.
Epileptic Disorders (2022) Vol. 24, Iss. 2, pp. 302-314
Closed Access | Times Cited: 13

Overexpressing wild‐type γ2 subunits rescued the seizure phenotype in Gabrg2+/Q390X Dravet syndrome mice
Xuan Huang, Chengwen Zhou, Mengnan Tian, et al.
Epilepsia (2017) Vol. 58, Iss. 8, pp. 1451-1461
Open Access | Times Cited: 24

Drug Development for Rare Paediatric Epilepsies: Current State and Future Directions
Stéphane Auvin, Andreja Avberšek, Thomas Bast, et al.
Drugs (2019) Vol. 79, Iss. 18, pp. 1917-1935
Closed Access | Times Cited: 20

Statins in primary prevention of poststroke seizures and epilepsy: A systematic review
Bruna Nucera, Fabrizio Rinaldi, Raffaele Nardone, et al.
Epilepsy & Behavior (2020) Vol. 112, pp. 107400-107400
Closed Access | Times Cited: 19

Gender issues in antiepileptogenic treatments
Asla Pitkänen, Noora Huusko, Xavier Ekolle Ndode‐Ekane, et al.
Neurobiology of Disease (2014) Vol. 72, pp. 224-232
Closed Access | Times Cited: 19

Impact of drug treatment and drug interactions in post-stroke epilepsy
Lanqing Zhao, Jinwei Li, Reetta Kälviäinen, et al.
Pharmacology & Therapeutics (2021) Vol. 233, pp. 108030-108030
Open Access | Times Cited: 16

Is the mechanism of action of antiseizure drugs a key element in the choice of treatment?
Déborah Guery, Sylvain Rheims
Fundamental and Clinical Pharmacology (2020) Vol. 35, Iss. 3, pp. 552-563
Closed Access | Times Cited: 14

Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases
Cinzia Costa, Elena Cesarini, Paolo Eusebi, et al.
Frontiers in Neurology (2022) Vol. 12
Open Access | Times Cited: 9

Exploring novel AEDs from drugs used for treatment of non-epileptic disorders
Chao Du, Fangshuo Zheng, Xuenfeng Wang
Expert Review of Neurotherapeutics (2016) Vol. 16, Iss. 4, pp. 449-461
Closed Access | Times Cited: 12

It’s About Time! Timing in Epilepsy Evaluation and Treatment
Heather McKee, Jorge Vidaurre, Dave Clarke, et al.
Epiliepsy currents/Epilepsy currents (2024)
Open Access | Times Cited: 1

Efficacy of perioperative anticonvulsant prophylaxis in seizure-naïve glioma patients: A meta-analysis
Xiaomeng Wang, Xueping Zheng, Song Hu, et al.
Clinical Neurology and Neurosurgery (2019) Vol. 186, pp. 105529-105529
Closed Access | Times Cited: 10

Methodological issues associated with clinical trials in epilepsy
Edoardo Ferlazzo, Chiara Sueri, Sara Gasparini, et al.
Expert Review of Clinical Pharmacology (2017) Vol. 10, Iss. 10, pp. 1103-1108
Closed Access | Times Cited: 9

A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization
Eugen Trinka, Wan Tsong, Sydney Toupin, et al.
Epilepsy Research (2020) Vol. 166, pp. 106403-106403
Closed Access | Times Cited: 9

Approach to the Medical Treatment of Epilepsy
Francesco Brigo, Anthony G Marson
CONTINUUM Lifelong Learning in Neurology (2022) Vol. 28, Iss. 2, pp. 483-499
Closed Access | Times Cited: 6

High glucose concentrations mask cellular phenotypes in a stem cell model of tuberous sclerosis complex
Paula Rocktäschel, Arjune Sen, M. Zameel Cader
Epilepsy & Behavior (2019) Vol. 101, pp. 106581-106581
Open Access | Times Cited: 8

Regulatory aspects of status epilepticus
Simon Shorvon, Eugen Trinka
Epilepsia (2018) Vol. 59, Iss. S2, pp. 128-134
Open Access | Times Cited: 6

Acute symptomatic seizures after stroke: A scoping review on primary prevention, treatment with antiseizure medications and drug discontinuation
Gaetano Zaccara, Simona Lattanzi, Francesco Brigo
Epilepsy & Behavior (2023) Vol. 149, pp. 109499-109499
Closed Access | Times Cited: 2

Challenges in the clinical development of new antiepileptic drugs
Valentina Franco, Jacqueline A. French, Emilio Perucca
Pharmacological Research (2015) Vol. 103, pp. 95-104
Closed Access | Times Cited: 4

Selecting the appropriate pharmacotherapy for epilepsy in patients with Alzheimer’s disease
Francesco Brigo
Expert Opinion on Pharmacotherapy (2018) Vol. 19, Iss. 16, pp. 1739-1741
Closed Access | Times Cited: 4

Psychiatric aspects of posttraumatic epilepsy: A still unexplored area
Marco Mula
Epilepsy & Behavior (2019) Vol. 101, pp. 106598-106598
Open Access | Times Cited: 4

Trends in new-onset epilepsy — the importance of comorbidities
Josemir W. Sander, Mark R. Keezer
Nature Reviews Neurology (2016) Vol. 12, Iss. 5, pp. 254-256
Closed Access | Times Cited: 3

Scroll to top